Sign in

CIK 0001660334

  • Non-accelerated filer
  • Smaller reporting company

Verrica Pharmaceuticals Inc.

Sign in to watch
Ticker
VRCA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
463137900
Phone
+1 484-453-3300
Business address
44 WEST GAY STREET, SUITE 400, WEST CHESTER, PA
  1. 4 Open-market sale Chief Commercial Officer sold 38,262 shares at $4.83 ($184,805)
  2. 4 Open-market sale President and CEO sold 50,677 shares at $4.83 ($244,770)
  3. 4 Open-market buy Director bought 200,000 shares at $5.02 ($1,004,000)
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4/A Open-market buy President and CEO bought 7,500 shares at $2.10 ($15,750)
  14. 4 Open-market buy Chief Legal Officer bought 7,500 shares at $3.40 ($25,500)
  15. 4 Open-market buy 10% owner bought 1,428,571 shares at $2.10 ($2,999,999)
  16. 4 Open-market buy Chief Legal Officer bought 5,714 shares at $2.10 ($11,999)
  17. 4 Open-market buy President and CEO bought 23,809 shares at $2.10 ($49,999)
  18. 4 Open-market buy Chief Medical Officer bought 23,809 shares at $2.10 ($49,999)
  19. 4 Open-market buy Director bought 238,095 shares at $2.10 ($500,000)
  20. 4 Open-market buy Director bought 4,761,904 shares at $2.10 ($9,999,998)

Page 5 of 13 · 253 filings